SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-9966
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma ; volume:41 ; number:1 ; day:19 ; month:4 ; year:2022 ; pages:1-18 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (19.4.2022), 1-18, 12.2022

Creator
Loria, Rossella
Laquintana, Valentina
Scalera, Stefano
Fraioli, Rocco
Caprara, Valentina
Falcone, Italia
Bazzichetto, Chiara
Martile, Marta Di
Rosanò, Laura
Bufalo, Donatella Del
Bossi, Gianluca
Sperduti, Isabella
Terrenato, Irene
Visca, Paolo
Soddu, Silvia
Milella, Michele
Ciliberto, Gennaro
Falcioni, Rita
Ferraresi, Virginia
Bon, Giulia
Contributor
SpringerLink (Online service)

DOI
10.1186/s13046-022-02354-w
URN
urn:nbn:de:101:1-2022073110400405847238
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Loria, Rossella
  • Laquintana, Valentina
  • Scalera, Stefano
  • Fraioli, Rocco
  • Caprara, Valentina
  • Falcone, Italia
  • Bazzichetto, Chiara
  • Martile, Marta Di
  • Rosanò, Laura
  • Bufalo, Donatella Del
  • Bossi, Gianluca
  • Sperduti, Isabella
  • Terrenato, Irene
  • Visca, Paolo
  • Soddu, Silvia
  • Milella, Michele
  • Ciliberto, Gennaro
  • Falcioni, Rita
  • Ferraresi, Virginia
  • Bon, Giulia
  • SpringerLink (Online service)

Other Objects (12)

Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma

Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models

Apoptoseinduktion durch BRAF, MEK Inhibition in humanen Melanomzellen

Hochschulschrift

Apoptoseinduktion durch BRAF, MEK Inhibition in humanen Melanomzellen

BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report

BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report

MEK + CDK4 a regimen for non-BRAF V6000 melanoma

MEK + CDK4 a regimen for non-BRAF V6000 melanoma

Zielgerichtete Kombinationstherapie von BRAF- und MEK-Inhibitor resistenten Melanomzellen

Zielgerichtete Kombinationstherapie von BRAF- und MEK-Inhibitor resistenten Melanomzellen

BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation

BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report

Brautpaar Braf

Bild

Brautpaar Braf

Braf, Albin

Abschnitt

Braf, Albin

Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells

Hochschulschrift

Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors

Related objects